Life-threatening adverse effects of pharmacologic antihyperuricemic therapy;Lebensbedrohliche nebenwirkungen der gichtbehandlung

Therapeutische Umschau

Volumn 61, Issue 9, 2004, Pages 575-577

  Russmann, St ^a   Lauterburg, Bernard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; BENZBROMARONE; MERCAPTOPURINE; URICOSURIC AGENT; XANTHINE OXIDASE;

DERMATITIS; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INHIBITION; ENZYME METABOLISM; EOSINOPHILIA; FEVER; HUMAN; HYPERURICEMIA; INCIDENCE; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; NEUTROPENIA; RASH; REVIEW; SIDE EFFECT; VASCULITIS;

ALLOPURINOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; EPIDERMAL NECROLYSIS, TOXIC; GOUT; HEPATITIS, TOXIC; HUMANS; URICOSURIC AGENTS; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 4544353350     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.9.575     Document Type: Review

References (10)

1. Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003; 349: 1647-1655.
2. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-1607.
3. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 337-343
4. Kumar A, Edward N, White MI, Johnston PW, Catto GR. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 1996; 312 (7024): 173-174
5. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76: 47-56.
6. Vazquez-Mellado J, Morales EM, Pacheco-Tena C, Burgos-Vargas R. Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis 2001; 60: 981-983.
7. Fam AG, Dunne SM, Iazzetta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 2001; 44: 231-238.
8. Jick H, Porter JB. Potentiation of ampicillin skin reactions by allopurinol or hyperuricemia. J Clin Pharmacol 1981; 21: 456-458.
9. Arai M, Yokosuka O, Fujiwara K, Kojima H, Kanda T, Hirasawa H et al. Fulminant hepatic failure associated with benzbromarone treatment: a case report. J Gastroenterol Hepatol 2002; 17: 625-626.
10. Wagayama H, Shiraki K, Sugimoto K, Fujikawa K, Shimizu A, Takase K et al. Fatal fulminant hepatic failure associated with benzbromarone. J Hepatol 2000; 32: 874.